
  
    
      
        Introduction_NNP
        The_DT Golgi_NNP complex_NN is_VBZ an_DT elaborate_JJ cytoplasmic_JJ organelle_NN
        that_WDT has_VBZ a_DT prominent_JJ function_NN in_IN the_DT processing_NN ,_,
        transporting_VBG ,_, and_CC sorting_VBG of_IN intracellular_NN proteins_NNS ._.
        Autoantibodies_NNP directed_VBD against_IN the_DT Golgi_NNP complex_NN were_VBD
        first_RB identified_VBN in_IN the_DT serum_NN of_IN a_DT Sjögren_NNP 's_POS syndrome_NN
        patient_NN with_IN lymphoma_NN [_NN 1_CD ]_NN ._. Subsequent_JJ reports_NNS described_VBD
        anti-_NN Golgi_NNP complex_JJ autoantibodies_NNS (_( AGA_NNP )_) in_IN patients_NNS with_IN
        systemic_JJ rheumatic_JJ diseases_NNS such_JJ as_IN systemic_JJ lupus_JJ
        erythematosus_JJ [_NN 2_CD ]_NN ,_, rheumatoid_NN arthritis_NN [_NN 3_CD ]_NN ,_, and_CC
        Wegener_NNP 's_POS granulomatosis_NNS [_NN 4_CD ]_NN ._. Immunoblotting_NNP and_CC
        immunoprecipitation_NN studies_NNS have_VBP shown_VBN that_IN there_EX was_VBD
        heterogeneity_NN of_IN reactivity_NN among_IN AGA_NNP [_NN 5_CD ]_NN ._.
        Within_IN the_DT past_JJ several_JJ years_NNS ,_, our_PRP$ laboratories_NNS and_CC
        others_NNS have_VBP cloned_VBN and_CC identified_VBN novel_NN Golgi_NNP autoantigens_NNS
        (_( golgins_NNS )_) [_NN 6_CD ]_NN ._. This_DT has_VBZ been_VBN achieved_VBN primarily_RB by_IN
        expression_NN cloning_VBG using_VBG human_JJ autoantibody_NN probes_NNS ._. The_DT
        identified_VBN autoantigens_NNS referred_VBD to_TO are_VBP golgin-_NN 160_CD /_NN GCP_NNP 170_CD [_NN
        7_CD 8_CD ]_NN ,_, golgin-_NN 95_CD /_NN gm_NN 130_CD [_NN 7_CD ]_NN ,_, golgin-_NN 97_CD [_NN 9_CD ]_NN ,_,
        golgin-_NN 245_CD /_NN p_NN 230_CD [_NN 10_CD 11_CD 12_CD ]_NN ,_, giantin_NN /_NN macrogolgin_NN /_NN GCP_NNP 372_CD
        [_NN 13_CD 14_CD ]_NN ,_, and_CC golgin-_NN 67_CD [_NN 15_CD ]_NN ._. These_DT proteins_NNS are_VBP
        characterized_VBN by_IN predominant_NN α-helical_JJ coiled-coil_JJ domains_NNS ,_,
        except_IN for_IN N-_NNP termini_NN and_CC C-_NNP termini_NN ._. It_PRP has_VBZ been_VBN reported_VBN
        that_IN some_DT golgins_NNS are_VBP localized_VBN to_TO the_DT cytoplasmic_JJ face_NN of_IN
        Golgi_NNP membranes_NNS [_NN 16_CD ]_NN ._. Functions_NNP of_IN the_DT golgins_NNS have_VBP been_VBN
        proposed_VBN in_IN vesicular_NN transport_NN and_CC in_IN maintaining_VBG
        structural_JJ integrity_NN of_IN the_DT Golgi_NNP complex_JJ [_NN 17_CD 18_CD 19_CD ]_NN ._.
        The_DT potential_JJ implication_NN is_VBZ that_IN these_DT Golgi_NNP proteins_NNS may_MD
        have_VB common_JJ biochemical_JJ characteristics_NNS that_WDT may_MD make_VB them_PRP
        targets_NNS of_IN autoimmune_JJ responses_NNS in_IN certain_JJ disease_NN
        states_NNS ._.
        It_PRP is_VBZ not_RB clear_JJ why_WRB and_CC how_WRB the_DT immune_JJ system_NN is_VBZ able_JJ to_TO
        recognize_VB or_CC target_VB intracellular_NN autoantigens_NNS ._. One_CD
        possible_JJ explanation_NN is_VBZ that_IN they_PRP may_MD be_VB recognized_VBN as_IN
        surface_NN structures_NNS on_IN cytoplasmic_JJ organelles_NNS that_WDT are_VBP
        released_VBN to_TO the_DT immune_JJ system_NN in_IN aberrant_NN disease_NN states_NNS
        associated_VBN with_IN unregulated_JJ cell_NN death_NN (_( apoptosis_NNS or_CC
        necrosis_NNS )_) resulting_VBG from_IN injury_NN or_CC infection_NN ,_, or_CC defective_JJ
        clearance_NN of_IN dying_VBG cells_NNS ._. A_DT variety_NN of_IN autoantigens_NNS are_VBP
        cleaved_JJ into_IN signature_NN fragments_NNS during_IN apoptosis_NNS and_CC
        necrosis_NNS [_NN 20_CD ]_NN ._. Other_JJ cell_NN death_NN post-translational_JJ
        modifications_NNS in_IN autoantigens_NNS include_VBP hyperphosphorylation_NN ,_,
        (_( de_IN )_) ubiquitination_NN ,_, methylation_NN ,_, citrullination_NN ,_, and_CC
        transglutaminase_NN crosslinking_VBG [_NN 21_CD 22_CD ]_NN ._.
        The_DT emerging_VBG view_NN is_VBZ that_WDT modified_VBN forms_NNS of_IN autoantigens_NNS
        generated_VBN during_IN cell_NN death_NN might_MD stimulate_VB autoantibody_NN
        responses_NNS if_IN presented_VBN to_TO the_DT immune_JJ system_NN in_IN a_DT
        proinflammatory_NN context_NN [_NN 23_CD ]_NN ._. Since_IN the_DT fate_NN of_IN the_DT
        Golgi_NNP complex_JJ during_IN cell_NN death_NN has_VBZ not_RB been_VBN extensively_RB
        explored_JJ ,_, we_PRP investigated_VBD whether_IN the_DT Golgi_NNP complex_JJ and_CC
        associated_VBN autoantigens_NNS are_VBP altered_VBN during_IN apoptosis_NNS and_CC
        necrosis_NNS ._. Using_VBG AGA_NNP as_IN probes_NNS ,_, we_PRP observed_VBD that_IN the_DT Golgi_NNP
        complex_JJ undergoes_NNS dynamic_JJ changes_NNS during_IN apoptosis_NNS distinct_JJ
        from_IN those_DT observed_VBN in_IN necrosis_NNS ._. Immunoblotting_NNP analysis_NN
        showed_VBD distinct_JJ cleavage_NN fragments_NNS of_IN Golgi_NNP autoantigens_NNS
        generated_VBN during_IN apoptosis_NNS and_CC necrosis_NNS ._. Since_IN the_DT cleaved_JJ
        Golgi_NNP autoantigen_NN fragments_NNS are_VBP antigenic_JJ ,_, they_PRP may_MD play_VB a_DT
        role_NN in_IN sustaining_VBG autoantibody_NN production_NN in_IN autoimmune_JJ
        disease_NN states_NNS ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Antibodies_NNP
          Human_JJ prototype_NN serum_NN containing_VBG highly_RB specific_JJ
          antipolyADP-ribose_JJ polymerase_NN (_( PARP_NNP )_) antibody_NN and_CC AGA_NNP
          sera_NN were_VBD obtained_VBN from_IN the_DT serum_NN bank_NN of_IN the_DT WM_NNP Keck_NNP
          Autoimmune_NNP Center_NNP ,_, The_DT Scripps_NNP Research_NNP Institute_NNP ,_, CA_NNP ,_,
          USA_NNP ._. Rabbit_NNP antibodies_NNS to_TO Golgi_NNP autoantigens_NNS were_VBD
          produced_VBN in_IN New_NNP Zealand_NNP White_NNP rabbits_NNS [_NN 7_CD 9_CD 10_CD ]_NN ._.
          Briefly_NNP ,_, recombinant_JJ human_JJ Golgi_NNP autoantigens_NNS were_VBD
          produced_VBN using_VBG the_DT expression_NN plasmid_NN pET_NN 28_CD system_NN in_IN 
          Escherichia_NNP coli_NNS (_( Novagen_NNP ,_, Madison_NNP ,_,
          WI_NNP ,_, USA_NNP )_) ._. Recombinant_NNP golgin-_NN 160_CD (_( amino_JJ acids_NNS 787_CD -_: 1348_CD ,_,
          GenBank_NNP accession_NN number_NN BAA_NNP 23661_CD )_) ,_, giantin_NN (_( amino_JJ acids_NNS
          851_CD -_: 1496_CD ,_, GenBank_NNP accession_NN number_NN NP_NNP __NN 004478_CD )_) ,_, gm_NN 130_CD
          (_( amino_JJ acids_NNS 370_CD -_: 990_CD ,_, GenBank_NNP accession_NN number_NN AAF_NNP 65550_CD )_) ,_,
          and_CC golgin-_NN 97_CD (_( amino_JJ acids_NNS 1_CD -_: 767_CD ,_, GenBank_NNP accession_NN
          number_NN AAB_NNP 81549_CD )_) proteins_NNS were_VBD purified_JJ by_IN affinity_NN
          nickel_NN column_NN chromatography_NN ._. They_PRP were_VBD then_RB used_VBN to_TO
          immunize_NN one_CD or_CC two_CD rabbits_NNS separately_RB by_IN subcutaneous_JJ
          injection_NN of_IN recombinant_JJ proteins_NNS in_IN an_DT equal_JJ volume_NN of_IN
          Freund_NNP 's_POS complete_JJ adjuvant_NN ._. After_IN booster_NN immunizations_NNS ,_,
          the_DT immune_JJ sera_NN were_VBD prepared_VBN and_CC stored_VBN at_IN -_: 20_CD °_NN C_NNP ._. The_DT
          appearance_NN and_CC titers_NNS of_IN antibodies_NNS were_VBD monitored_VBN by_IN
          indirect_JJ immunofluorescence_NN and_CC immunoblotting_VBG
          analysis_NN ._.
        
        
          Induction_NNP of_IN cell_NN death_NN
          Human_NNP Jurkat_NNP and_CC HEp-_NNP 2_CD cells_NNS were_VBD obtained_VBN from_IN
          American_NNP Type_NNP Culture_NNP Collection_NNP (_( Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_) and_CC
          were_VBD cultured_JJ in_IN RPMI_NNP 1640_CD and_CC Dulbecco_NNP 's_POS modified_VBN
          Eagle_NNP 's_POS medium_NN (_( Life_NNP Technologies_NNPS ,_, Rockville_NNP ,_, MD_NNP ,_, USA_NNP )_) ,_,
          respectively_RB ,_, containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN under_IN
          standard_JJ conditions_NNS ._. Induction_NNP of_IN cell_NN death_NN was_VBD
          performed_VBN essentially_RB as_IN described_VBN elsewhere_RB [_NN 20_CD ]_NN with_IN
          some_DT modifications_NNS ._.
          Apoptosis_NNP was_VBD induced_VBN in_IN Jurkat_NNP T_NN cells_NNS (_( 10_CD 6_CD /_NN ml_NN )_) by_IN
          exposure_NN to_TO 1_CD μM_NN staurosporine_NN (_( STS_NNP )_) (_( ALEXIS_NNP ,_, San_NNP Diego_NNP ,_,
          CA_NNP ,_, USA_NNP )_) for_IN up_IN to_TO 4_CD hours_NNS ._. Apoptosis_NNP in_IN HEp-_NNP 2_CD cells_NNS was_VBD
          induced_VBN by_IN exposure_NN to_TO 2_CD μM_NN STS_NNP at_IN 37_CD °_NN C_NNP for_IN up_IN to_TO 6_CD
          hours_NNS ._. Necrosis_NNP was_VBD induced_VBN in_IN these_DT cells_NNS by_IN exposure_NN to_TO
          10_CD μM_NN STS_NNP for_IN up_IN to_TO 24_CD hours_NNS or_CC by_IN treatment_NN with_IN 0_CD ._. 1_CD %_NN
          hydrogen_NN peroxide_NN (_( H_NNP 
          2_CD O_NNP 
          2_LS )_) (_( Fisher_NNP Scientific_NNP ,_, Pittsburgh_NNP ,_,
          PA_NNP ,_, USA_NNP )_) for_IN 3_CD hours_NNS ._. Necrosis_NNP was_VBD quantified_VBN using_VBG the_DT
          trypan_NN blue_JJ exclusion_NN assay_NN ,_, which_WDT measures_VBZ loss_NN of_IN
          cytoplasmic_JJ membrane_NN integrity_NN ,_, as_IN described_VBN previously_RB [_NN
          20_CD 24_CD ]_NN ._.
          At_IN least_JJS 300_CD cells_NNS were_VBD counted_VBN in_IN triplicate_NN in_IN three_CD
          independent_JJ experiments_NNS ._. In_IN some_DT experiments_NNS ,_, Jurkat_NNP
          cells_NNS were_VBD incubated_JJ for_IN 1_CD hour_NN in_IN the_DT presence_NN of_IN the_DT
          pancaspase_NN inhibitor_NN
          benzylocarbonyl-_NN Val-_NNP Ala-_NNP Asp-fluromethyl-ketone_NNP (_( zVAD-fmk_JJ )_)
          (_( ALEXIS_NNP )_) ,_, used_VBN at_IN 100_CD μM_NN ,_, prior_RB to_TO addition_NN of_IN STS_NNP ._.
          Treated_NNP and_CC control_NN cells_NNS ,_, and_CC their_PRP$ extracts_NNS ,_, were_VBD
          analyzed_VBN by_IN indirect_JJ immunofluorescence_NN and_CC /_NN or_CC
          immunoblotting_VBG analysis_NN ._. Spontaneous_NNP cell_NN death_NN prior_RB to_TO
          the_DT experiments_NNS was_VBD minimized_VBN by_IN maintaining_VBG exponential_NN
          cell_NN growth_NN ._. Cell_NNP viability_NN was_VBD quantified_VBN by_IN trypan_NN blue_JJ
          exclusion_NN analysis_NN at_IN the_DT beginning_NN of_IN every_DT experiment_NN
          to_TO ensure_VB that_IN cell_NN cultures_NNS used_VBN in_IN the_DT experiments_NNS were_VBD
          healthy_JJ (_( alive_JJ cells_NNS >_NN 95_CD %_NN )_) ._.
        
        
          Indirect_JJ immunofluorescence_NN microscopy_NN
          Indirect_JJ immunofluorescence_NN was_VBD performed_VBN as_IN reported_VBN
          previously_RB [_NN 7_CD 10_CD 25_CD ]_NN ._. HEp-_NNP 2_CD cells_NNS were_VBD grown_VBN on_IN
          eight-chamber_JJ vessel_NN tissue_NN culture_NN slides_NNS (_( Becton_NNP
          Dickinson_NNP ,_, Franklin_NNP Lakes_NNP ,_, NJ_NNP ,_, USA_NNP )_) and_CC treated_VBN with_IN 2_CD or_CC
          10_CD μM_NN STS_NNP for_IN up_IN to_TO 6_CD hours_NNS ._. Cells_NNP were_VBD fixed_VBN by_IN methanol_NN
          and_CC acetone_NN (_( 1_CD :_: 3_CD ,_, -_: 20_CD °_NN C_NNP )_) for_IN 2_CD min_NN ._. Sera_NNP containing_VBG AGA_NNP
          were_VBD used_VBN in_IN dilutions_NNS of_IN 1_CD :_: 200_CD to_TO 1_CD :_: 10_CD ,_, 000_CD ._. The_DT
          secondary_JJ antibodies_NNS were_VBD Alexa_NNP ™_NN 488_CD conjugated_JJ goat_NN
          anti-rabbit_JJ IgG_NNP or_CC anti-human_JJ IgG_NNP reagents_NNS (_( ALEXIS_NNP )_) ._.
          Cells_NNP were_VBD counterstained_JJ with_IN
          4_CD '_POS ,_, 6_CD -_: diamidino-_NN 2_CD -_: phenylindole_NN nuclear_JJ stain_VB prior_RB to_TO
          immunofluorescence_NN microscopy_NN ._. The_DT estimation_NN of_IN the_DT
          percentage_NN of_IN cells_NNS at_IN each_DT morphological_JJ stage_NN described_VBD
          in_IN the_DT following_VBG for_IN Golgi_NNP staining_VBG in_IN apoptotic_JJ cells_NNS
          was_VBD obtained_VBN by_IN scoring_VBG 300_CD -_: 500_CD cells_NNS in_IN each_DT
          experiment_NN ._.
        
        
          Immunoblotting_NNP analysis_NN of_IN cell_NN lysates_NNS
          After_IN incubation_NN in_IN the_DT presence_NN of_IN
          cell-death-inducing_JJ reagents_NNS ,_, Jurkat_NNP cells_NNS were_VBD
          centrifuged_JJ at_IN 200_CD ×_NN 
          g_SYM for_IN 30_CD min_NN ,_, followed_VBN by_IN one_CD wash_VB
          at_IN 1000_CD ×_NN 
          g_SYM for_IN 10_CD min_NN in_IN PBS_NNP containing_VBG
          Complete_JJ Protease_NNP Inhibitor_NNP cocktail_NN (_( Roche_NNP ,_, Mannheim_NNP ,_,
          Germany_NNP )_) ._. Cell_NNP pellets_NNS (_( 10_CD 7_CD )_) were_VBD then_RB resuspended_JJ
          directly_RB in_IN lysis_NNS buffer_NN containing_VBG 150_CD mM_NN NaCl_NNP ,_, 1_CD mM_NN
          MgCl_NNP 
          2_CD ·_NN 6_CD H_NNP 
          2_CD O_NNP ,_, 80_CD mM_NN Tris-_NNP HCl_NNP and_CC 0_CD ._. 1_CD %_NN
          NP-_NNP 40_CD ._.
          The_DT lysates_NNS were_VBD passed_VBN several_JJ times_NNS sequentially_RB
          through_IN 18_CD -_: gauge_VB to_TO 27_CD -_: gauge_VB needles_NNS to_TO shear_NN the_DT DNA_NNP ,_,
          and_CC protein_NN concentrations_NNS in_IN the_DT lysates_NNS were_VBD determined_VBN
          by_IN Protein_NNP DC_NNP Assay_NNP Kit_NNP (_( Bio-_NNP Rad_NNP ,_, Hercules_NNP ,_, CA_NNP ,_, USA_NNP )_) to_TO
          ensure_VB equal_JJ loading_NN of_IN proteins_NNS in_IN each_DT SDS-PAGE_NNP lane_NN ._.
          After_IN determination_NN of_IN the_DT protein_NN concentration_NN ,_, lysates_NNS
          were_VBD mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN 2_CD ×_NN gel_NN sample_NN buffer_NN
          containing_VBG 6_CD %_NN sodium_NN dodecyl_NN sulfate_NN ,_, 20_CD %_NN glycerol_NN ,_, 10_CD %_NN
          β-mercaptoethanol_JJ ,_, 0_CD ._. 02_CD %_NN bromphenol_NN blue_JJ and_CC Complete_JJ
          Protease_NNP Inhibitor_NNP cocktail_NN ._. Lysates_NNP were_VBD stored_VBN at_IN -_: 80_CD °_NN C_NNP
          until_IN use_NN ._.
          The_DT equivalent_NN of_IN 1_CD ._. 5_CD μg_NN total_JJ lysate_NN protein_NN was_VBD
          loaded_VBN onto_IN each_DT lane_NN of_IN 10_CD %_NN SDS-PAGE_NNP gels_NNS ,_, separated_VBN by_IN
          electrophoresis_NNS ,_, and_CC transferred_VBD to_TO nitrocellulose_NN
          membranes_NNS using_VBG a_DT Semi-_NNP Dry_NNP Trans-_NNP Blot_NNP apparatus_NN
          (_( Bio-_NNP Rad_NNP )_) ._. Immunoblotting_NNP was_VBD performed_VBN as_IN described_VBN
          previously_RB [_NN 7_CD 10_CD 24_CD ]_NN using_VBG human_JJ anti-_NN PARP_NNP specific_JJ
          antibody_NN (_( 1_CD :_: 250_CD )_) and_CC AGA_NNP (_( 1_CD :_: 250_CD )_) ._. Detection_NNP of_IN bound_VBN
          antibodies_NNS was_VBD achieved_VBN using_VBG horseradish_NN
          peroxidase-conjugated_JJ goat_NN anti-human_JJ or_CC anti-rabbit_JJ IgG_NNP
          antibody_NN (_( CALTAG_NNP ,_, San_NNP Francisco_NNP ,_, CA_NNP ,_, USA_NNP )_) ,_, used_VBN at_IN 1_CD :_: 5000_CD
          dilution_NN ,_, in_IN combination_NN with_IN enhanced_JJ chemiluminescence_NN
          (_( Super_NNP Signal_NNP ;_: PIERCE_NNP Products_NNPS ,_, Rockford_NNP ,_, IL_NNP ,_, USA_NNP )_) ._.
        
      
      
        Results_NNS
        
          Induction_NNP of_IN apoptosis_NNS and_CC necrosis_NNS in_IN HEp-_NNP 2_CD
          cells_NNS
          HEp-_NNP 2_CD cells_NNS exposed_VBN to_TO 2_CD and_CC 10_CD μM_NN STS_NNP exhibited_VBN
          apoptotic-like_JJ fragmentation_NN into_IN multiple_JJ round_NN bodies_NNS
          after_IN 6_CD hours_NNS of_IN treatment_NN (_( Fig_NNP ._. 1_LS c_SYM ,_, 1_CD d_SYM )_) ._. Interestingly_RB ,_,
          cells_NNS exposed_VBN to_TO 10_CD μM_NN STS_NNP showed_VBD a_DT more_RBR pronounced_JJ loss_NN
          of_IN cytoplasmic_JJ membrane_NN integrity_NN (_( Fig_NNP ._. 1_LS e_SYM )_) ,_, indicating_VBG
          that_IN this_DT STS_NNP concentration_NN drove_VBD cell_NN death_NN more_RBR rapidly_RB
          into_IN necrosis_NNS ._. As_IN control_NN ,_, cells_NNS treated_VBN with_IN levels_NNS of_IN H_NNP
          
          2_LS O_NNP 
          2_CD (_( 0_CD ._. 1_LS %_NN )_) previously_RB shown_VBN to_TO provoke_VB
          massive_JJ necrotic_JJ cell_NN death_NN [_NN 20_CD ]_NN exhibited_VBN a_DT
          characteristic_JJ necrotic_JJ morphology_NN (_( Fig_NNP ._. 1_LS b_SYM )_) associated_VBN
          with_IN rapid_JJ loss_NN of_IN cytoplasmic_JJ membrane_NN (_( Fig_NNP ._. 1_LS e_SYM )_) ._.
        
        
          Changes_NNS of_IN the_DT Golgi_NNP complex_JJ during_IN
          apoptosis_NNS
          Changes_NNS in_IN the_DT Golgi_NNP complex_JJ during_IN apoptosis_NNS were_VBD
          examined_VBN by_IN immunostaining_VBG with_IN AGA_NNP in_IN HEp-_NNP 2_CD cells_NNS
          treated_VBN with_IN 2_CD μM_NN STS_NNP ._. Apoptosis_NNP was_VBD defined_VBN by_IN
          stereotypic_JJ morphological_JJ changes_NNS ,_, especially_RB evident_JJ in_IN
          the_DT nucleus_NN ,_, where_WRB the_DT chromatin_NN condenses_NNS and_CC compacts_NNS ,_,
          and_CC assumes_VBZ a_DT globular_NN ,_, crescent-shaped_JJ morphology_NN [_NN 26_CD ]_NN
          ._. Figure_NN 2_CD shows_VBZ a_DT composite_NN of_IN four_CD apoptotic_JJ stages_NNS ,_,
          provisionally_RB called_VBN stages_NNS I-IV_NNP (_( Fig_NNP ._. 2_LS b_SYM ,_, 2_CD c_SYM ,_, 2_CD d_SYM ,_, 2_CD e_SYM )_) ,_, that_WDT
          are_VBP classified_VBN on_IN the_DT basis_NN of_IN progression_NN of_IN apoptotic_JJ
          nuclear_JJ change_NN (_( middle_JJ panels_NNS )_) and_CC corresponding_JJ staining_VBG
          for_IN golgin-_NN 97_CD (_( left_VBD panels_NNS )_) ._.
          About_IN 50_CD -_: 60_CD %_NN of_IN cells_NNS appeared_VBD unaffected_JJ after_IN 2_CD
          hours_NNS of_IN incubation_NN in_IN the_DT presence_NN of_IN STS_NNP ,_, as_IN evidenced_VBN
          by_IN perinuclear_NN Golgi_NNP staining_VBG identical_JJ to_TO untreated_JJ
          cells_NNS (_( Fig_NNP ._. 2_LS a_DT )_) ._. Interestingly_RB ,_, '_'' swelling_VBG '_POS of_IN the_DT Golgi_NNP
          complex_JJ with_IN vesicular_NN staining_VBG (_( stage_NN I_PRP )_) was_VBD observed_VBN in_IN
          10_CD -_: 20_CD %_NN of_IN cells_NNS ,_, and_CC is_VBZ most_RBS strikingly_RB demonstrated_VBN in_IN
          Fig_NNP ._. 2_LS b_SYM ._. It_PRP is_VBZ estimated_VBN that_IN the_DT area_NN occupied_VBN by_IN the_DT
          swelled_VBN Golgi_NNP can_MD be_VB ~_NN 5_CD -_: 10_CD times_NNS the_DT normal_JJ size_NN for_IN
          Golgi_NNP complex_JJ in_IN HEp-_NNP 2_CD cells_NNS ._. Slight_NNP changes_NNS in_IN the_DT shape_NN
          of_IN some_DT nuclei_NN were_VBD observed_VBN ,_, as_IN shown_VBN in_IN the_DT middle_JJ
          panel_NN ,_, but_CC most_JJS cells_NNS with_IN Golgi_NNP swelling_VBG exhibited_VBN no_DT
          change_NN in_IN nuclear_JJ size_NN and_CC shape_NN ._.
          About_IN 10_CD %_NN of_IN cells_NNS appeared_VBD to_TO be_VB in_IN stage_NN II_NNP (_( Fig_NNP ._.
          2_LS c_SYM )_) where_WRB there_EX was_VBD elongation_NN of_IN the_DT nucleus_NN ,_, appearing_VBG
          kidney_NN or_CC crescent_NN shaped_VBN (_( middle_JJ panel_NN )_) ._. A_DT
          characteristic_NN of_IN stage_NN II_NNP was_VBD that_IN the_DT Golgi_NNP complex_NN was_VBD
          condensed_JJ at_IN the_DT concave_NN or_CC indented_JJ region_NN of_IN the_DT
          crescentic_JJ nucleus_NN (_( right_JJ panel_NN )_) ._. Stage_NNP III_NNP (_( Fig_NNP ._. 2_LS d_SYM )_) was_VBD
          seen_VBN in_IN 3_CD -_: 5_CD %_NN of_IN cells_NNS with_IN defined_VBN nuclear_JJ fragmentation_NN
          into_IN two_CD approximately_RB equal_JJ fragments_NNS (_( middle_JJ panel_NN )_) and_CC
          golgin-_NN 97_CD primarily_RB located_VBN at_IN the_DT cleavage_NN zone_NN between_IN
          the_DT two_CD nuclear_JJ fragments_NNS (_( right_JJ panel_NN )_) ._. About_IN 10_CD -_: 15_CD %_NN of_IN
          the_DT cells_NNS were_VBD considered_VBN to_TO be_VB at_IN stage_NN IV_NNP (_( Fig_NNP ._. 2_LS e_SYM )_) ,_,
          where_WRB their_PRP$ nuclei_NN were_VBD fragmented_JJ into_IN more_JJR than_IN two_CD
          pieces_NNS (_( middle_JJ panel_NN )_) and_CC golgin-_NN 97_CD staining_VBG appeared_VBN as_IN
          vesicular_NN structures_NNS ._. This_DT was_VBD the_DT final_JJ stage_NN when_WRB
          remnants_NNS of_IN the_DT Golgi_NNP complex_NN could_MD be_VB detected_VBN ._.
          Evaluation_NNP of_IN cells_NNS after_IN 6_CD hours_NNS of_IN incubation_NN with_IN 2_CD
          μM_NN STS_NNP showed_VBD all_DT four_CD stages_NNS described_VBD (_( data_NNS not_RB shown_VBN )_) ._.
          At_IN this_DT time_NN ,_, up_IN to_TO 50_CD %_NN of_IN cells_NNS were_VBD in_IN stage_NN I_PRP ,_, 20_CD %_NN
          were_VBD in_IN stage_NN II_NNP ,_, 2_CD -_: 3_CD %_NN were_VBD in_IN stage_NN III_NNP ,_, and_CC 25_CD %_NN of_IN
          cells_NNS were_VBD in_IN stage_NN IV_NNP ._. These_DT data_NNS suggested_VBD that_IN
          STS-treated_NNP cells_NNS do_VBP not_RB enter_VB the_DT apoptotic_JJ pathway_NN at_IN
          the_DT same_JJ time_NN ,_, which_WDT is_VBZ consistent_JJ with_IN the_DT notion_NN that_IN
          apoptosis_NNS is_VBZ a_DT relatively_RB asynchronous_JJ process_NN ._.
          Similar_JJ staining_VBG patterns_NNS to_TO those_DT seen_VBN with_IN golgin-_NN 97_CD
          were_VBD observed_VBN when_WRB apoptotic_JJ HEp-_NNP 2_CD cells_NNS were_VBD stained_JJ
          with_IN antibodies_NNS to_TO golgin-_NN 95_CD ,_, golgin-_NN 160_CD ,_, golgin-_NN 245_CD ,_, and_CC
          giantin_NN (_( data_NNS not_RB shown_VBN )_) ._. These_DT results_NNS were_VBD also_RB
          reproduced_VBD in_IN HeLa_NNP S_NNP 3_CD and_CC mouse_NN J_NNP 774_CD A_DT ._. 1_LS cells_NNS treated_VBN
          with_IN 2_CD μM_NN STS_NNP (_( data_NNS not_RB shown_VBN )_) ._. The_DT amount_NN of_IN Golgi_NNP
          swelling_VBG observed_VBN in_IN stage_NN I_PRP varied_VBD in_IN different_JJ
          experiments_NNS ,_, but_CC the_DT characteristics_NNS for_IN stages_NNS II-IV_NNP
          were_VBD highly_RB reproducible_JJ in_IN all_PDT the_DT experiments_NNS we_PRP have_VBP
          conducted_VBN ._. Our_PRP$ observations_NNS of_IN Golgi_NNP swelling_VBG during_IN
          apoptosis_NNS are_VBP supported_VBN by_IN previous_JJ studies_NNS ._. For_IN
          instance_NN ,_, in_IN neurons_NNS undergoing_VBG apoptosis_NNS ,_, morphologic_JJ
          changes_NNS were_VBD characterized_VBN by_IN a_DT highly_RB ordered_VBN sequence_NN
          of_IN organelle_NN abnormalities_NNS ,_, with_IN swelling_VBG of_IN endoplasmic_JJ
          reticulum_NN and_CC Golgi_NNP vesiculation_NN that_WDT preceded_VBN most_RBS
          nuclear_JJ changes_NNS or_CC mitochondrial_NN disruption_NN [_NN 27_CD 28_CD ]_NN
          ._.
        
        
          Changes_NNS of_IN the_DT Golgi_NNP complex_JJ during_IN necrosis_NNS
          In_IN contrast_NN to_TO the_DT Golgi_NNP swelling_VBG already_RB described_VBD ,_,
          striking_JJ fragmentation_NN of_IN the_DT Golgi_NNP complex_NN was_VBD observed_VBN
          during_IN necrosis_NNS in_IN HEp-_NNP 2_CD cells_NNS treated_VBN with_IN 10_CD μM_NN STS_NNP
          (_( Fig_NNP ._. 2_LS f_SYM )_) ._. As_IN shown_VBN in_IN Fig_NNP ._. 1_LS b_SYM ,_, 1_CD e_SYM ,_, approximately_RB 50_CD %_NN of_IN
          cells_NNS treated_VBN with_IN this_DT STS_NNP concentration_NN ,_, while_IN
          initially_RB showing_VBG apoptotic-like_JJ fragmentation_NN into_IN
          multiple_JJ bodies_NNS ,_, gradually_RB died_VBN by_IN necrosis_NNS ._. Figure_NN
          2_CD fshows_NNS Golgi_NNP fragments_NNS clearly_RB visible_JJ (_( arrows_NNS )_) in_IN cells_NNS
          with_IN condensed_JJ nuclei_NN after_IN 6_CD hours_NNS of_IN treatment_NN with_IN 10_CD
          μM_NN STS_NNP ._. Note_VB the_DT absence_NN of_IN nuclear_JJ fragmentation_NN in_IN
          these_DT cells_NNS compared_VBN with_IN apoptotic_JJ cells_NNS (_( Fig_NNP ._. 2_LS e_SYM )_) ,_,
          consistent_JJ with_IN previous_JJ observations_NNS showing_VBG that_IN
          necrotic_JJ nuclei_NN exhibit_NN condensation_NN but_CC not_RB
          fragmentation_NN [_NN 20_CD ]_NN ._. In_IN this_DT treatment_NN ,_, designed_VBN to_TO
          drive_VB apoptotic_JJ cells_NNS more_RBR rapidly_RB into_IN necrosis_NNS ,_, changes_NNS
          in_IN the_DT Golgi_NNP complex_JJ similar_JJ to_TO the_DT four_CD stages_NNS observed_VBD
          in_IN apoptosis_NNS were_VBD not_RB detected_VBN ._. Similar_JJ results_NNS were_VBD also_RB
          obtained_VBN for_IN other_JJ Golgi_NNP autoantigens_NNS ,_, including_VBG
          golgin-_NN 160_CD ,_, giantin_NN ,_, and_CC golgin-_NN 95_CD (_( data_NNS not_RB shown_VBN )_) ._.
          No_DT Golgi_NNP staining_VBG was_VBD observed_VBN in_IN HEp-_NNP 2_CD cells_NNS treated_VBN
          with_IN 10_CD μM_NN STS_NNP for_IN 24_CD hours_NNS or_CC with_IN 0_CD ._. 1_CD %_NN H_NNP 
          2_CD O_NNP 
          2_CD (_( data_NNS not_RB shown_VBN )_) ,_, presumably_RB due_JJ to_TO
          the_DT extensive_JJ cytoplasmic_JJ damage_NN associated_VBN with_IN
          necrosis_NNS ._. These_DT results_NNS suggested_VBD that_IN the_DT Golgi_NNP complex_NN
          is_VBZ affected_VBN differently_RB in_IN apoptosis_NNS and_CC in_IN necrosis_NNS ,_,
          prompting_VBG us_PRP to_TO examine_VB whether_IN specific_JJ Golgi_NNP proteins_NNS
          are_VBP targeted_VBN for_IN proteolysis_NNS in_IN these_DT modes_NNS of_IN cell_NN
          death_NN ._.
        
        
          Golgi_NNP autoantigens_NNS are_VBP cleaved_JJ during_IN apoptosis_NNS and_CC
          necrosis_NNS
          It_PRP is_VBZ well_RB established_VBN that_IN specific_JJ intracellular_NN
          autoantigens_NNS are_VBP cleaved_JJ into_IN different_JJ fragments_NNS in_IN
          Jurkat_NNP T_NN cells_NNS and_CC other_JJ cell_NN types_NNS undergoing_VBG apoptosis_NNS
          and_CC necrosis_NNS [_NN 20_CD ]_NN ._. Mancini_NNP 
          et_CC al_NN ._. reported_VBD that_DT golgin-_NN 160_CD
          (_( native_JJ protein_NN ,_, 160_CD kDa_NN )_) was_VBD cleaved_JJ into_IN a_DT 140_CD kDa_NN
          fragment_NN during_IN apoptosis_NNS [_NN 29_CD ]_NN ._. We_PRP therefore_RB performed_VBD
          an_DT immunoblotting_VBG analysis_NN using_VBG extracts_NNS from_IN Jurkat_NNP
          cells_NNS treated_VBN with_IN apoptosis-inducing_JJ reagent_NN (_( 1_CD μM_NN STS_NNP )_)
          or_CC necrosis-inducing_JJ reagent_NN (_( 0_CD ._. 1_LS %_NN H_NNP 
          2_CD O_NNP 
          2_LS )_) to_TO investigate_VB whether_IN Golgi_NNP
          autoantigens_NNS are_VBP cleaved_JJ in_IN the_DT two_CD major_JJ types_NNS of_IN cell_NN
          death_NN ._. PARP_NNP (_( 110_CD kDa_NN protein_NN )_) was_VBD selected_VBN as_IN a_DT positive_JJ
          control_NN to_TO monitor_VB the_DT cleavage_NN of_IN proteins_NNS during_IN
          apoptosis_NNS and_CC necrosis_NNS because_IN its_PRP$ cleavage_NN products_NNS in_IN
          Jurkat_NNP cells_NNS undergoing_VBG apoptosis_NNS (_( 89_CD kDa_NN )_) and_CC undergoing_VBG
          necrosis_NNS (_( 60_CD and_CC 50_CD kDa_NN )_) are_VBP well_RB established_VBN [_NN 20_CD 24_CD 30_CD
          ]_NN ._.
          Figure_NN 3_CD shows_VBZ the_DT results_NNS of_IN immunoblotting_VBG analysis_NN
          using_VBG antibodies_NNS to_TO PARP_NNP and_CC four_CD Golgi_NNP autoantigens_NNS ._. In_IN
          cells_NNS treated_VBN with_IN STS_NNP (_( Fig_NNP ._. 3_LS ,_, left_VBD )_) or_CC H_NNP 
          2_CD O_NNP 
          2_CD (_( Fig_NNP ._. 3_LS ,_, right_NN )_) ,_, PARP_NNP was_VBD cleaved_JJ
          into_IN an_DT 89_CD kDa_NN polypeptide_NN (_( apoptotic_JJ fragments_NNS )_) or_CC 60_CD
          and_CC 50_CD kDa_NN polypeptides_NNS (_( necrotic_JJ fragments_NNS )_) ,_,
          respectively_RB ,_, with_IN complete_JJ degradation_NN of_IN native_JJ protein_NN
          as_RB previously_RB described_VBD [_NN 24_CD ]_NN ._. Golgin-_NNP 160_CD was_VBD cleaved_JJ
          into_IN 140_CD and_CC 80_CD kDa_NN fragments_NNS in_IN apoptotic_JJ cells_NNS ,_,
          consistent_JJ with_IN published_VBN observations_NNS [_NN 29_CD ]_NN ._. In_IN
          contrast_NN to_TO the_DT apoptotic_JJ fragments_NNS ,_, a_DT 70_CD kDa_NN fragment_NN
          was_VBD detected_VBN in_IN necrotic_JJ cells_NNS ._. Giantin_NNP was_VBD cleaved_JJ into_IN
          three_CD major_JJ apoptotic_JJ fragments_NNS (_( 150_CD ,_, 80_CD ,_, and_CC 60_CD kDa_NN )_) ,_,
          and_CC these_DT fragments_NNS were_VBD clearly_RB different_JJ from_IN the_DT 75_CD
          and_CC 50_CD kDa_NN fragments_NNS derived_VBN from_IN necrosis_NNS ._.
          Interestingly_RB ,_, while_IN apoptotic_JJ fragments_NNS of_IN golgin-_NN 95_CD and_CC
          golgin-_NN 97_CD were_VBD not_RB detected_VBN ,_, necrotic_JJ fragments_NNS at_IN 50_CD and_CC
          70_CD kDa_NN were_VBD detected_VBN for_IN both_DT proteins_NNS ._. A_DT summary_NN of_IN the_DT
          Golgi_NNP protein_NN fragments_NNS generated_VBN during_IN apoptosis_NNS and_CC
          necrosis_NNS is_VBZ presented_VBN in_IN Table_NNP 1_CD ._.
        
        
          Proteolysis_NNP of_IN Golgi_NNP autoantigens_NNS induced_VBN by_IN
          apoptosis_NNS is_VBZ caspase_NN dependent_JJ
          The_DT caspase_NN family_NN of_IN proteases_NNS plays_VBZ a_DT central_JJ role_NN
          in_IN apoptosis_NNS by_IN participating_VBG in_IN a_DT cascade_NN of_IN cleavage_NN
          events_NNS that_WDT result_NN in_IN the_DT apoptotic_JJ phenotype_NN [_NN 31_CD ]_NN ._. We_PRP
          investigated_VBD whether_IN the_DT proteolysis_NNS of_IN Golgi_NNP
          autoantigens_NNS caused_VBN by_IN treatment_NN with_IN STS_NNP was_VBD caspase_NN
          dependent_JJ ._. Jurkat_NNP cells_NNS were_VBD treated_VBN with_IN 1_CD μM_NN STS_NNP for_IN 4_CD
          hours_NNS after_IN preincubation_NN with_IN the_DT pan-caspase_JJ inhibitor_NN
          100_CD μM_NN zVAD-fmk_JJ ._. The_DT generation_NN of_IN proteolytic_JJ fragments_NNS
          from_IN Golgi_NNP autoantigens_NNS was_VBD completely_RB blocked_VBN in_IN Jurkat_NNP
          cells_NNS pretreated_JJ with_IN zVAD-fmk_JJ (_( Fig_NNP ._. 4_LS )_) ,_, indicating_VBG that_DT
          cleavage_NN of_IN Golgi_NNP autoantigens_NNS during_IN apoptosis_NNS is_VBZ
          mediated_JJ by_IN caspases_NNS ._.
        
      
      
        Discussion_NNP
        
          Apoptotic_NNP changes_NNS of_IN the_DT Golgi_NNP complex_JJ
          Lane_NNP 
          et_CC al_NN ._. reported_VBD recently_RB that_IN the_DT
          Golgi_NNP complex_JJ in_IN HeLa_NNP cells_NNS is_VBZ fragmented_VBN into_IN scattered_VBN
          vesicles_NNS by_IN caspases_NNS due_JJ to_TO interference_NN of_IN Golgi_NNP
          reassembly_RB and_CC abnormalities_NNS of_IN the_DT 65_CD kDa_NN stacking_VBG
          protein_NN GRASP_NNP 65_CD [_NN 32_CD ]_NN ._. In_IN the_DT present_JJ report_NN ,_, we_PRP
          describe_VBP characteristic_JJ changes_NNS of_IN the_DT Golgi_NNP complex_JJ
          during_IN the_DT progression_NN of_IN apoptosis_NNS ._. It_PRP is_VBZ not_RB known_VBN
          whether_IN the_DT Golgi_NNP complex_JJ functions_NNS as_IN a_DT stress_NN sensor_NN
          involved_VBN in_IN the_DT regulation_NN of_IN apoptosis_NNS ._. Mancini_NNP 
          et_CC al_NN ._. reported_VBD that_DT caspase-_NN 2_CD was_VBD
          localized_JJ at_IN the_DT Golgi_NNP complex_JJ and_CC generated_VBD a_DT unique_JJ
          cleavage_NN product_NN of_IN golgin-_NN 160_CD [_NN 29_CD ]_NN ._. Furthermore_RB ,_,
          these_DT investigators_NNS proposed_VBN that_IN the_DT Golgi_NNP complex_JJ
          transduces_NNS proapoptotic_JJ signals_NNS [_NN 29_CD ]_NN ._. A_DT precedent_NN for_IN
          this_DT hypothesis_NNS was_VBD provided_VBN by_IN Nakagawa_NNP 
          et_CC al_NN ._. ,_, who_WP reported_VBD that_DT
          caspase-_NN 12_CD is_VBZ localized_VBN to_TO the_DT endoplasmic_JJ reticulum_NN and_CC
          mediates_NNS an_DT endoplasmic_JJ reticulum-specific_JJ apoptosis_NNS
          pathway_NN [_NN 33_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, we_PRP have_VBP found_VBN that_IN
          all_DT Golgi_NNP autoantigens_NNS examined_VBD were_VBD cleaved_JJ in_IN apoptosis_NNS
          in_IN a_DT caspase-dependent_JJ manner_NN ,_, as_IN evidenced_VBN by_IN studies_NNS
          showing_VBG that_IN the_DT pan-caspase_JJ inhibitor_NN zVAD-fmk_JJ
          completely_RB blocked_VBD the_DT apoptotic_JJ fragmentation_NN of_IN these_DT
          antigens_NNS ._. Although_IN the_DT requirement_NN for_IN specific_JJ caspases_NNS
          was_VBD not_RB examined_VBN here_RB ,_, it_PRP is_VBZ possible_JJ that_WDT caspases_NNS
          localized_VBN in_IN the_DT Golgi_NNP complex_JJ (_( including_VBG caspase-_NN 2_LS )_)
          transduce_NN death_NN signals_NNS during_IN the_DT early_JJ stages_NNS of_IN
          apoptosis_NNS that_WDT are_VBP associated_VBN with_IN fragmentation_NN of_IN
          specific_JJ Golgi_NNP proteins_NNS ._.
          It_PRP has_VBZ been_VBN reported_VBN that_IN apoptotic_JJ death_NN receptors_NNS
          such_JJ as_IN CD_NNP 95_CD [_NN 34_CD ]_NN ,_, tumor_NN necrosis_NNS factor-related_JJ
          apoptosis_NNS inducing_VBG ligand_NN receptor_NN 1_CD ,_, tumor_NN necrosis_NNS
          factor-related_JJ apoptosis_NNS inducing_VBG ligand_NN receptor_NN 2_CD [_NN 35_CD
          ]_NN ,_, and_CC tumor_NN necrosis_NNS factor_NN receptor_NN 1_CD [_NN 36_CD ]_NN are_VBP
          enriched_JJ in_IN the_DT Golgi_NNP complex_JJ prior_RB to_TO transport_VB to_TO the_DT
          plasma_NN membrane_NN ,_, thus_RB suggesting_VBG that_IN the_DT Golgi_NNP complex_NN
          may_MD play_VB an_DT important_JJ role_NN in_IN apoptotic_JJ signalling_VBG ._. We_PRP
          now_RB provide_VBP evidence_NN for_IN characteristic_JJ alterations_NNS in_IN
          the_DT Golgi_NNP complex_JJ corresponding_JJ to_TO nuclear_JJ change_NN during_IN
          the_DT progression_NN of_IN apoptosis_NNS ._. Swelling_NNP of_IN the_DT Golgi_NNP
          complex_NN was_VBD particularly_RB detected_VBN in_IN the_DT early_JJ stages_NNS of_IN
          apoptosis_NNS ._. It_PRP could_MD be_VB speculated_VBN that_IN apoptotic_JJ
          alterations_NNS of_IN the_DT Golgi_NNP complex_NN may_MD facilitate_VB the_DT
          transportation_NN of_IN death_NN receptors_NNS from_IN the_DT Golgi_NNP complex_JJ
          to_TO the_DT plasma_NN membrane_NN ,_, and_CC may_MD amplify_VB the_DT apoptotic_JJ
          events_NNS once_RB apoptosis_NNS was_VBD initiated_VBN ._. Additional_JJ studies_NNS
          are_VBP needed_VBN to_TO examine_VB the_DT precise_JJ function_NN of_IN the_DT Golgi_NNP
          complex_JJ during_IN apoptosis_NNS ._.
        
        
          Role_NNP of_IN apoptotic_JJ or_CC necrotic_JJ fragments_NNS in_IN
          autoantibody_NN production_NN
          Analysis_NNP of_IN post-translational_JJ modifications_NNS in_IN
          intracellular_NN autoantigens_NNS associated_VBN with_IN apoptosis_NNS and_CC
          necrosis_NNS should_MD provide_VB important_JJ insights_NNS into_IN the_DT
          possible_JJ role_NN of_IN cell_NN death_NN in_IN the_DT generation_NN of_IN
          potentially_RB autoantigenic_JJ forms_NNS of_IN cellular_JJ antigens_NNS ._.
          Casciola-_NNP Rosen_NNP and_CC coworkers_NNS have_VBP proposed_VBN that_IN
          modifications_NNS of_IN autoantigens_NNS during_IN cell_NN death_NN ,_,
          particularly_RB proteolytic_JJ cleavage_NN ,_, might_MD be_VB crucial_JJ for_IN
          the_DT generation_NN of_IN autoantibodies_NNS in_IN autoimmune_JJ diseases_NNS [_NN
          23_CD 37_CD ]_NN ._. Unique_NNP proteolytic_JJ fragments_NNS of_IN α-fodrin_JJ and_CC
          type_NN 3_CD muscarinic_JJ acetylcholine_NN receptor_NN have_VBP been_VBN
          implicated_VBN in_IN the_DT generation_NN of_IN autoantibody_NN responses_NNS in_IN
          primary_JJ Sjögren_NNP 's_POS syndrome_NN [_NN 38_CD 39_CD ]_NN ._.
          Although_IN direct_JJ evidence_NN that_DT autoantigen_NN cleavage_NN
          fragments_NNS produced_VBN during_IN cell_NN death_NN elicit_NN autoantibody_NN
          responses_NNS is_VBZ still_RB scarce_JJ ,_, Pollard_NNP 
          et_CC al_NN ._. reported_VBD that_DT immunization_NN
          of_IN B_NNP 10_CD ._. S_NNP mice_NNS (_( H-_NNP 2_CD s_VBZ )_) with_IN a_DT 19_CD kDa_NN proteolytic_JJ cleavage_NN
          fragment_NN of_IN fibrillarin_NN (_( derived_VBN from_IN nonapoptotic_JJ cell_NN
          death_NN )_) elicited_JJ antibodies_NNS that_WDT are_VBP comparable_JJ with_IN human_JJ
          anti-fibrillarin_JJ autoantibodies_NNS and_CC those_DT derived_VBN from_IN
          mice_NNS exposed_VBN to_TO mercury_NN [_NN 40_CD ]_NN ._. In_IN a_DT study_NN using_VBG human_JJ
          sera_NN ,_, Greidinger_NNP 
          et_CC al_NN ._. reported_VBD that_IN the_DT
          recognition_NN of_IN apoptosis-derived_JJ and_CC oxidatively_RB modified_VBN
          forms_NNS of_IN the_DT 70_CD kDa_NN subunit_NN of_IN U_NNP 1_CD small_JJ nuclear_JJ
          ribonucleoprotein_NN autoantigen_NN was_VBD associated_VBN with_IN
          distinct_JJ disease_NN manifestations_NNS [_NN 41_CD ]_NN ._. Furthermore_RB ,_,
          Oriss_NNP 
          et_CC al_NN ._. demonstrated_VBN that_IN a_DT
          combination_NN of_IN antigen-processing_JJ cells_NNS and_CC a_DT fragment_NN of_IN
          DNA_NNP topoisomerase_NN I_PRP efficiently_RB elicited_JJ autoreactive_JJ
          T-_NNP cell_NN proliferation_NN ,_, whereas_IN the_DT full-length_JJ
          topoisomerase_NN I_PRP required_VBD additional_JJ stimulus_NN of_IN exogenous_JJ
          interleukin-_NN 2_CD [_NN 42_CD ]_NN ._.
          These_DT data_NNS point_VBP to_TO a_DT crucial_JJ role_NN for_IN fragments_NNS of_IN
          autoantigens_NNS in_IN the_DT generation_NN of_IN autoantibody_NN responses_NNS ._.
          In_IN the_DT present_JJ study_NN ,_, several_JJ Golgi_NNP autoantigens_NNS were_VBD
          detected_VBN cleaved_JJ into_IN distinctive_JJ fragments_NNS during_IN
          apoptosis_NNS and_CC necrosis_NNS ._. It_PRP has_VBZ been_VBN speculated_VBN that_IN these_DT
          modified_VBN forms_NNS of_IN autoantigens_NNS may_MD have_VB enhanced_JJ
          immunogenicity_NN through_IN exposure_NN of_IN immunocryptic_JJ epitopes_NNS
          that_WDT are_VBP not_RB generated_VBN during_IN antigen_NN processing_NN [_NN 21_CD 23_CD
          37_CD 43_CD ]_NN ._. These_DT epitopes_NNS could_MD trigger_VB autoimmune_JJ
          responses_NNS if_IN presented_VBN to_TO the_DT immune_JJ system_NN under_IN
          proinflammatory_NN conditions_NNS [_NN 44_CD ]_NN ,_, and_CC they_PRP may_MD be_VB
          recognized_VBN as_IN surface_NN structures_NNS on_IN cytoplasmic_JJ
          organelles_NNS that_WDT are_VBP released_VBN to_TO the_DT immune_JJ system_NN in_IN
          aberrant_NN disease_NN states_NNS ._.
          Autoantibody_NNP responses_NNS could_MD be_VB amplified_VBN and_CC
          maintained_VBN on_IN repeated_VBN stimulation_NN if_IN the_DT exposure_NN of_IN
          intracellular_NN antigens_NNS to_TO the_DT immune_JJ system_NN is_VBZ associated_VBN
          with_IN defective_JJ clearance_NN of_IN apoptotic_JJ cells_NNS ,_, prolonged_JJ
          necrosis_NNS (_( primary_JJ or_CC secondary_JJ )_) ,_, T-_NNP cell_NN cytotoxicity_NN
          associated_VBN with_IN chronic_JJ infection_NN ,_, or_CC even_RB antigen_NN
          mutation_NN or_CC overexpression_NN ._. It_PRP would_MD be_VB important_JJ not_RB
          only_RB to_TO assess_VB the_DT immunogenic_JJ potential_NN of_IN subcellular_NN
          particles_NNS and_CC proteolytic_JJ fragments_NNS released_VBN during_IN cell_NN
          death_NN ,_, but_CC also_RB to_TO continue_VB investigating_VBG possible_JJ
          defects_NNS leading_VBG to_TO aberrant_NN apoptosis_NNS or_CC phagocyte_NN
          function_NN and_CC /_NN or_CC aberrant_NN antigen_NN expression_NN in_IN systemic_JJ
          autoimmune_JJ diseases_NNS ._.
        
        
          Kinetics_NNP of_IN degradation_NN of_IN golgins_NNS and_CC generation_NN
          of_IN apoptotic_JJ fragments_NNS
          Although_IN only_RB well-defined_JJ apoptotic_JJ fragments_NNS of_IN
          golgin-_NN 160_CD and_CC giantin_NN ,_, not_RB of_IN golgin-_NN 95_CD and_CC golgin-_NN 97_CD ,_,
          were_VBD detected_VBN after_IN 2_CD or_CC 4_CD hours_NNS of_IN incubation_NN with_IN STS_NNP ,_,
          total_JJ disappearance_NN of_IN intact_JJ proteins_NNS was_VBD detected_VBN with_IN
          all_DT Golgi_NNP autoantigens_NNS and_CC complete_JJ blockage_NN was_VBD observed_VBN
          in_IN the_DT presence_NN of_IN z-_NN VAD-fmk_NNP ._. These_DT results_NNS suggested_VBD
          that_IN there_EX might_MD be_VB differences_NNS in_IN the_DT kinetics_NNS of_IN
          degradation_NN among_IN the_DT golgins_NNS ,_, with_IN golgin-_NN 95_CD and_CC
          golgin-_NN 97_CD perhaps_RB being_VBG more_RBR sensitive_JJ to_TO proteolysis_NNS and_CC
          being_VBG targeted_VBN very_RB early_RB during_IN apoptosis_NNS ._. While_IN the_DT
          absence_NN of_IN apoptotic_JJ fragments_NNS for_IN golgin-_NN 95_CD and_CC
          golgin-_NN 97_CD suggests_VBZ that_IN total_JJ degradation_NN of_IN these_DT
          proteins_NNS occurred_VBD without_IN generation_NN of_IN intermediate_JJ
          protease-resistant_JJ fragments_NNS ,_, it_PRP cannot_NN be_VB ruled_VBN out_RP that_IN
          the_DT intact_JJ proteins_NNS were_VBD released_VBN from_IN apoptotic_JJ cells_NNS or_CC
          that_IN their_PRP$ apoptotic_JJ fragments_NNS were_VBD not_RB recognized_VBN by_IN
          autoantibodies_NNS ._.
          In_IN the_DT present_JJ study_NN ,_, Jurkat_NNP cells_NNS were_VBD relatively_RB
          sensitive_JJ to_TO the_DT treatment_NN with_IN STS_NNP such_JJ that_IN the_DT
          kinetics_NNS of_IN degradation_NN of_IN different_JJ golgins_NNS relative_JJ to_TO
          that_DT of_IN PARP_NNP could_MD not_RB be_VB accurately_RB differentiated_JJ ._.
          Since_IN HEp-_NNP 2_CD cells_NNS grown_VBN as_IN a_DT monolayer_NN were_VBD observed_VBN to_TO
          be_VB more_RBR resistant_JJ to_TO apoptosis_NNS compared_VBN with_IN Jurkat_NNP
          cells_NNS ,_, we_PRP used_VBD HEp-_NNP 2_CD cells_NNS to_TO investigate_VB more_RBR precisely_RB
          the_DT relative_JJ kinetics_NNS of_IN degradation_NN for_IN the_DT native_JJ
          golgins_NNS during_IN apoptosis_NNS ._.
          An_DT identical_JJ pattern_NN of_IN fragmentation_NN was_VBD essentially_RB
          observed_VBN for_IN all_PDT the_DT Golgi_NNP autoantigens_NNS examined_VBD except_IN
          that_IN the_DT overall_JJ kinetics_NNS of_IN native_JJ protein_NN degradation_NN
          was_VBD slower_JJR (_( data_NNS not_RB shown_VBN )_) ._. The_DT integrity_NN of_IN native_JJ
          golgin-_NN 95_CD and_CC golgin-_NN 97_CD ,_, in_IN which_WDT apoptotic_JJ fragments_NNS
          were_VBD not_RB detected_VBN ,_, was_VBD almost_RB completely_RB maintained_VBN at_IN 12_CD
          hours_NNS after_IN the_DT addition_NN of_IN STS_NNP (_( data_NNS not_RB shown_VBN )_) ._. In_IN
          contrast_NN ,_, native_JJ golgin-_NN 160_CD and_CC giantin_NN were_VBD degraded_JJ
          into_IN their_PRP$ respective_JJ fragments_VBZ 12_CD hours_NNS after_IN the_DT
          addition_NN of_IN STS_NNP ._. The_DT processing_NN of_IN golgin-_NN 160_CD and_CC giantin_NN
          occurred_VBD as_RB early_RB as_IN that_DT for_IN PARP_NNP ,_, suggesting_VBG that_IN these_DT
          proteins_NNS are_VBP cleaved_JJ during_IN the_DT onset_NN of_IN apoptosis_NNS (_( data_NNS
          not_RB shown_VBN )_) ._. Cleavage_NNP of_IN golgin-_NN 160_CD and_CC giantin_NN may_MD thus_RB
          play_VB a_DT potentially_RB important_JJ role_NN in_IN the_DT early_JJ stages_NNS of_IN
          apoptosis_NNS ._.
          Although_IN we_PRP did_VBD not_RB determine_VB which_WDT golgins_NNS are_VBP
          substrates_NNS for_IN specific_JJ caspases_NNS ,_, further_JJ studies_NNS aimed_VBN
          at_IN defining_VBG the_DT caspases_NNS responsible_JJ for_IN golgin_NN cleavage_NN ,_,
          the_DT cleavage_NN sites_NNS ,_, and_CC the_DT biological_JJ consequences_NNS of_IN
          these_DT cleavages_NNS should_MD provide_VB important_JJ insights_NNS into_IN
          the_DT possible_JJ role_NN of_IN some_DT of_IN the_DT Golgi_NNP autoantigens_NNS in_IN
          apoptosis_NNS ._.
        
      
      
        Conclusion_NNP
        The_DT present_JJ study_NN has_VBZ shown_VBN overall_JJ morphologic_JJ changes_NNS
        of_IN the_DT Golgi_NNP complex_JJ during_IN apoptosis_NNS and_CC necrosis_NNS ,_, with_IN
        distinct_JJ fragmentation_NN patterns_NNS of_IN its_PRP$ associated_VBN
        autoantigens_NNS ._. We_PRP propose_VBP that_DT cleavage_NN of_IN golgin-_NN 160_CD and_CC
        giantin_NN may_MD play_VB a_DT role_NN in_IN early_JJ events_NNS in_IN apoptosis_NNS ._. We_PRP
        also_RB speculate_VBP that_IN Golgi_NNP fragmentation_NN in_IN cell_NN death_NN might_MD
        participate_VB in_IN sustaining_VBG autoantibody_NN response_NN to_TO the_DT
        Golgi_NNP complex_JJ in_IN aberrant_NN disease_NN states_NNS characterized_VBN by_IN
        unregulated_JJ cell_NN death_NN resulting_VBG from_IN injury_NN or_CC infection_NN
        or_CC defective_JJ clearance_NN of_IN dying_VBG cells_NNS ._.
      
      
        Abbreviations_NNP
        AGA_NNP =_SYM anti-_NN Golgi_NNP complex_JJ autoantibodies_NNS ;_: H_NNP 
        2_CD O_NNP 
        2_CD =_SYM hydrogen_NN peroxide_NN ;_: PARP_NNP =_SYM
        polyADP-ribose_JJ polymerase_NN ;_: PBS_NNP =_SYM phosphate-buffered_JJ saline_NN ;_:
        STS_NNP =_SYM staurosporine_NN ;_: zVAD-fmk_JJ =_SYM
        benzylocarbonyl-_NN Val-_NNP Ala-_NNP Asp-fluromethylketone_NNP ._.
      
    
  
